Selinexor With ICE Chemotherapy in Secondary Central Nervous System Involving B-cell Non-Hodgkin Lymphoma

NCT06552559 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

37

Enrollment

OTHER

Sponsor class

Conditions

B-cell Lymphoma Recurrent
B-cell Lymphoma Refractory
CNS Metastases

Interventions

DRUG: Selinexor

Sponsor

Samsung Medical Center

Collaborators

[object Object]